Chinese Academy of Medical Sciences
- Country
- 🇨🇳China
- Ownership
- Private, Subsidiary
- Established
- 2004-07-08
- Employees
- -
- Market Cap
- -
Maintenance Treatment of Chidamide in Stage IV or Relapsed/Refractory Extranodal NK/T-cell Lymphoma
- Conditions
- First Posted Date
- 2018-08-15
- Last Posted Date
- 2018-08-15
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 32
- Registration Number
- NCT03630731
- Locations
- 🇨🇳
Cancer Hospital and Institute, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, Beijing, China
SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer
- First Posted Date
- 2018-07-27
- Last Posted Date
- 2020-02-11
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 45
- Registration Number
- NCT03603756
- Locations
- 🇨🇳
Jing Huang, Beijing, China
Randomized Trial of Accelerated Partial Breast Irradiation
- Conditions
- Interventions
- First Posted Date
- 2018-07-11
- Last Posted Date
- 2020-03-25
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 140
- Registration Number
- NCT03583619
- Locations
- 🇨🇳
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
Accelerated Partial Breast Irradiation With IMRT in Early Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2018-07-11
- Last Posted Date
- 2022-01-11
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 537
- Registration Number
- NCT03583580
- Locations
- 🇨🇳
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC
- Conditions
- Interventions
- First Posted Date
- 2018-06-28
- Last Posted Date
- 2020-07-15
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 44
- Registration Number
- NCT03572829
- Locations
- 🇨🇳
National Cancer Center/ Cancer Hospital, Chinese Academy of Medcal science and Peking Union Medical College, Beijing, China
New Strategy of Improving Treatment Outcome and Larynx-preservation Rate in Locally Advanced Hypopharyngeal Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2018-06-15
- Last Posted Date
- 2021-01-29
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 96
- Registration Number
- NCT03558035
- Locations
- 🇨🇳
Cancer hospital, Chinese Academy of Medical Sciences, Beijing, China
Safety and Efficacy of Anlotinib in Combination With Irinotecan in Patients With Pretreated Advanced Colorectal Cancer
- First Posted Date
- 2018-06-04
- Last Posted Date
- 2018-08-06
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 42
- Registration Number
- NCT03545711
- Locations
- 🇨🇳
Jing Huang, Beijing, China
Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer
- First Posted Date
- 2018-05-24
- Last Posted Date
- 2020-12-02
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 32
- Registration Number
- NCT03535961
- Locations
- 🇨🇳
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric Cancer
- Conditions
- Interventions
- First Posted Date
- 2018-02-09
- Last Posted Date
- 2018-02-09
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 18
- Registration Number
- NCT03427684
- Locations
- 🇨🇳
Cancer Hospital, Chinese academy of medical sciences, Beijing, Beijing, China
Factors Influencing Cancer Patients Participation in Clinical Trials in China.
- Conditions
- First Posted Date
- 2018-01-26
- Last Posted Date
- 2018-01-26
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 300
- Registration Number
- NCT03412344
- Locations
- 🇨🇳
Cancer Institute/Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, Beijing, China